Helius Medical Technologies (NASDAQ: HSDT) is one of 59 public companies in the “Electromedical equipment” industry, but how does it weigh in compared to its competitors? We will compare Helius Medical Technologies to related businesses based on the strength of its risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.
This is a breakdown of recent ratings and target prices for Helius Medical Technologies and its competitors, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Helius Medical Technologies||0||0||0||0||N/A|
|Helius Medical Technologies Competitors||337||993||1688||86||2.49|
As a group, “Electromedical equipment” companies have a potential upside of 10.67%. Given Helius Medical Technologies’ competitors higher possible upside, analysts clearly believe Helius Medical Technologies has less favorable growth aspects than its competitors.
Institutional and Insider Ownership
8.0% of Helius Medical Technologies shares are held by institutional investors. Comparatively, 45.2% of shares of all “Electromedical equipment” companies are held by institutional investors. 9.9% of Helius Medical Technologies shares are held by company insiders. Comparatively, 16.2% of shares of all “Electromedical equipment” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Volatility & Risk
Helius Medical Technologies has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. Comparatively, Helius Medical Technologies’ competitors have a beta of 21.44, indicating that their average stock price is 2,044% more volatile than the S&P 500.
This table compares Helius Medical Technologies and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Helius Medical Technologies||-2,965.26%||-289.95%||-188.52%|
|Helius Medical Technologies Competitors||-464.38%||-97.56%||-13.37%|
Earnings and Valuation
This table compares Helius Medical Technologies and its competitors gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Helius Medical Technologies||$1.50 million||-$9.78 million||-1.08|
|Helius Medical Technologies Competitors||$1.01 billion||$120.03 million||23.53|
Helius Medical Technologies’ competitors have higher revenue and earnings than Helius Medical Technologies. Helius Medical Technologies is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Helius Medical Technologies competitors beat Helius Medical Technologies on 10 of the 10 factors compared.
About Helius Medical Technologies
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.
Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.